Accenture ACN has signed an eight-year application outsourcing
agreement with Astellas Pharma Inc. (TSE:4503, “Astellas”). As part of
the contract, Accenture will deliver application development and
maintenance services to the leading pharmaceutical company,
which researches, develops and manufactures prescription drugs.
Accenture will help modernize and standardize Astellas' core business
systems, such as accounting, production management, purchasing and
supply chain management in its Japan, North America and European
regions. Accenture will leverage its Global
Delivery Network locations in India, China and Brazil to support the
engagement.
Astellas' objective for the engagement is to prepare a foundation for
accelerated globalization of its business.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in